Seeking Alpha
 

Sequenom, Inc. (SQNM)

- NASDAQ
  • Nov. 9, 2012, 12:45 PM
    Midday top 10 gainers: HWG +66%. KIPS +41%. KYAK +27%. ZIP +25%. SQNM +22%. UBNT +19%. DGIT +17%. SQI +16%. CYTX +16%. ISIS +15%. Midday top 10 Losers: GRPN -27%. DTSI -26%. SCLN -24%. IDN -23%. RNDY -21%. III -17%. ADEP -17%. OSG -17%. STRA -16%. PTIX -15%.
    | Comment!
  • Nov. 8, 2012, 5:17 PM
    Sequenom (SQNM): Q3 EPS loss of $0.26 misses by $0.02. Revenue $22.9M misses by $280K. (PR)
    | Comment!
  • Nov. 8, 2012, 12:10 AM
    Notable earnings after Thursday’s close: AFFY, AGO, CBOU, CUBE, DAR, DGIT, DIS, DLB, DNN, EGLE, EVEP, GRPN, HALO, HOGS, IGT, IO, JAZZ, JWN, LGF, MCHP, MDRX, MKL, NVDA, PSA, RNDY, SD, SPRD, SQNM, UBNT, WPRT, WR, ZGNX, ZIP
    | Comment!
  • Nov. 7, 2012, 5:35 PM
    Notable earnings after Thursday’s close: AFFY, AGO, CBOU, CUBE, DAR, DGIT, DIS, DLB, DNN, EGLE, EVEP, GRPN, HALO, HOGS, IGT, IO, JAZZ, JWN, LGF, MCHP, MDRX, MKL, NVDA, PSA, RNDY, SD, SPRD, SQNM, UBNT, WPRT, WR, ZGNX, ZIP
    | Comment!
  • Sep. 17, 2012, 6:40 PM
    Sequenom (SQNM) says it's completed its private offering of $130M aggregate principal amount of 5% convertible senior notes due 2017. The company plans to use the proceeds to fund the commercialization of the MaterniT21 PLUS laboratory-developed test, as well as for other general corporate purposes.
    | 1 Comment
  • Sep. 11, 2012, 9:10 AM
    Premarket gainers: WSB +91%. SNSS +48%. CTIC +15%. NOK +7%. CRTX +7%. RBS +6%. PSTI +5%.
    Losers: NAVB -31%. PPO -12%. PANW -8%. SQNM -7%. PPHM -6%.
    | Comment!
  • Sep. 10, 2012, 5:38 PM
    Sequenom (SQNM) announces a $100M private offering of convertible senior notes due 2017, with a 30-day option to purchase up to an additional $20M to cover over-allotments. The company plans to use the proceeds to fund the commercialization of its MaterniT21 PLUS laboratory-developed test, as well as for R&D, capital expenditures, working capital and general administrative expenses. Shares -7.5% AH.
    | Comment!
  • Aug. 28, 2012, 9:16 AM
    Sequenom (SQNM) +3.9% premarket on news its subsidiary has completed several international distribution agreements that will expand access to the MaterniT21 PLUS testing service outside the U.S. MaterniT21 PLUS is intended for use in pregnant women at increased risk for fetal aneuploidy and can be used as early as 10 weeks gestation.
    | Comment!
  • Aug. 16, 2012, 9:10 AM
    Premarket gainers: BTH +23%. VQ +17%. EA +10%. SINA +8%. CSTR +8%. OCZ +8%. CSCO +7%. SQNM +6%. PETM +6%.
    Losers: IDIX -39%. MCP -8%. NTES -8%. A -7%. DLTR -6%.
    | 1 Comment
  • Aug. 3, 2012, 9:15 AM
    Premarket gainers: OPEN +19%. MELI +17%. SKUL +13%. LNKD +11%. ATPG +11%. VHC +10%. KOG +10%. KCG +10%. STEM +8%. SQNM +8%. DB +7%. ING +7%. WFR +7%. E +6%. SI +5%. MT +5%. ATAX +5%. BCS +5%.
    Losers: ZIP -35%. HNT -24%. BODY -18%. MCP -15%. XIDE -13%. REE -8%. GLUU -7%. ONNN -7%.
    | Comment!
  • Jul. 26, 2012, 6:27 PM
    Sequenom (SQNM): Q2 EPS of -$0.26 misses by $0.05. Revenue of $18.3M (+37.6% Y/Y) misses by $0.89M. Shares -3.8% AH. (PR)
    | Comment!
  • Jul. 6, 2012, 12:09 PM
    Sequenom (SQNM -4.2%) sinks after a California District Court denied its petition for an injunction against Ariosa Diagnostics to prevent the company from offering or selling its Harmony Prenatal Test, pending resolution of current litigation between the two companies.
    | Comment!
  • Jul. 6, 2012, 9:10 AM
    Premarket gainers: BOOT +81%. PCX +10%. JRCC +6%.
    Losers: INFA -30%. ALXA -11%. APKT -10%. AONE -8%. SQNM -6%.
    | Comment!
  • May. 17, 2012, 5:24 PM
    Sequenom (SQNM) says the recently announced provider network participation agreement with Coventry Health Care (CVH) has been terminated without cause by Coventry. The agreement was intended to provide members in the network with coverage for Sequenom CMM's MaterniT21 PLUS laboratory-developed test. SQNM -7.8% AH.
    | Comment!
  • May. 9, 2012, 4:54 PM
    The big move higher in Zillow (Z) over the past 2 weeks takes on a bit more interest with the disclosure Stevie Cohen's SAC Capital has accumulated a 5% stake in the company. The hedge fund has also increased positions or taken new stakes in Sequenom (SQNM), Western Refining (WNR), YELP, and Walter Energy (WLT), among others.
    | 1 Comment
  • May. 3, 2012, 8:29 PM
    Sequenom (SQNM): Q1 EPS of -$0.22 misses by $0.03. Revenue of $14.9M (+10.4% Y/Y) misses by $1.4M. Shares -3% AH. (PR)
    | Comment!
Visit Seeking Alpha's
SQNM vs. ETF Alternatives
Company Description
Sequenom Inc is a molecular diagnostic testing and genetics analysis company which provides molecular diagnostic testing services.
Sector: Healthcare
Industry: Biotechnology
Country: United States